Balentine LLC Amgen Inc Transaction History

Balentine LLC

$2.54 Billion
Q3 2024

A detailed history of Balentine LLC transactions in Amgen Inc stock. As of the latest transaction made, Balentine LLC holds 830 shares of AMGN stock, worth $244,459. This represents 0.01% of its overall portfolio holdings.

Number of Shares

830

Previous 827 0.36%

Holding current value

$244,459

Previous $258,000 3.49%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$309.38 - $337.38 $928 - $1,012	3 Added 0.36%	830 $267,000
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $1.98 Million - $2.4 Million	-7,525 Reduced 90.1%	827 $258,000
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $149,760 - $180,779	557 Added 7.15%	8,352 $2.37 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $440,571 - $497,016	1,723 Added 28.38%	7,795 $2.25 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $305,672 - $379,501	1,398 Added 29.91%	6,072 $1.63 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $67,066 - $79,304	-313 Reduced 6.28%	4,674 $1.04 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $419,743 - $511,596	-1,859 Reduced 27.15%	4,987 $1.21 Million
Q4 2022 Jan 31, 2023	BUY	$229.03 - $291.01 $22,444 - $28,518	98 Added 1.45%	6,846 $1.8 Million
Q3 2022 Oct 26, 2022	BUY	$224.46 - $253.15 $101,904 - $114,930	454 Added 7.21%	6,748 $1.52 Million
Q2 2022 Oct 26, 2022	BUY	$230.71 - $256.74 $437,656 - $487,035	1,897 Added 43.14%	6,294 $1.53 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $1.45 Million - $1.62 Million	6,294 New	6,294 $1.53 Million
Q1 2022 Oct 26, 2022	SELL	$219.27 - $242.57 $415,955 - $460,155	-1,897 Reduced 30.14%	4,397 $1.06 Million
Q4 2021 Oct 26, 2022	SELL	$198.88 - $227.6 $741,026 - $848,037	-3,726 Reduced 59.2%	2,568 $578,000
Q4 2021 Feb 02, 2022	SELL	$198.88 - $227.6 $262,919 - $300,887	-1,322 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $3,820 - $4,476	-18 Reduced 1.34%	1,322 $281,000
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $98,337 - $109,097	-421 Reduced 23.91%	1,340 $327,000
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $57,696 - $67,236	260 Added 17.32%	1,761 $438,000
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $6,275 - $7,472	29 Added 1.97%	1,501 $345,000
Q3 2020 Nov 02, 2020	BUY	$234.65 - $260.95 $35,666 - $39,664	152 Added 11.52%	1,472 $374,000
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $147,368 - $180,841	745 Added 129.57%	1,320 $311,000
Q1 2020 May 18, 2020	SELL	$182.24 - $241.7 $80,003 - $106,106	-439 Reduced 43.29%	575 $117,000
Q4 2019 Sep 02, 2020	BUY	$189.21 - $243.2 $157,611 - $202,585	833 Added 460.22%	1,014 $244,000
Q3 2019 Nov 15, 2019	BUY	$174.11 - $208.62 $8,357 - $10,013	48 Added 36.09%	181 $35,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $11,168 - $13,092	67 Added 101.52%	133 $25,000
Q1 2019 May 16, 2019	SELL	$180.87 - $203.88 $9,586 - $10,805	-53 Reduced 44.54%	66 $13,000
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $22,049 - $24,857	119 New	119 $25,000
Q1 2018 May 16, 2018	SELL	$169.43 - $198.0 $203,654 - $237,996	-1,202 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $19,579 - $21,876	116 Added 10.68%	1,202 $209,000
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $181,676 - $207,426	1,086	1,086 $202,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.

Account